已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Prognostic implication of NQO1 overexpression in hepatocellular carcinoma

肝细胞癌 免疫组织化学 比例危险模型 医学 危险系数 生存分析 内科学 阶段(地层学) 癌症研究 肿瘤科 生物标志物 存活率 总体生存率 胃肠病学 六氯环己烷 癌变 病理 生物 癌症 置信区间 古生物学 生物化学
作者
Lijuan Lin,Jie Sun,Yan Tan,Zhenling Li,Fanyong Kong,Yue Shen,Chao Liu,Litian Chen
出处
期刊:Human Pathology [Elsevier BV]
卷期号:69: 31-37 被引量:39
标识
DOI:10.1016/j.humpath.2017.09.002
摘要

To explore the role of NQO1 overexpression for prognostic implication in hepatocellular carcinoma (HCC), NQO1 mRNA levels were detected in HCC fresh tissue samples of HCC and nontumor tissues, respectively. One hundred fifty-six cases of HCC meeting strict follow-up criteria were selected for immunohistochemical staining of NQO1 protein. Correlations between NQO1 overexpression and clinicopathological features of HCC were evaluated using χ2 tests, survival rates were calculated using the Kaplan-Meier method, and the relationship between prognostic factors and patient 5-year survival was analyzed using Cox proportional hazards analysis. In results, the levels of NQO1 mRNA were significantly up-regulated in 14 fresh tissue samples of HCC. Immunohistochemical analysis showed that the NQO1 expression and overexpression rates were significantly higher in HCC samples compared with either adjacent nontumor tissues or normal liver tissues. NQO1 overexpression correlated to tumor size, venous infiltration and late pTNM stage of HCC. NQO1 overexpression was also related to low disease-free survival and 5-year survival rates. In the late‐stage group, disease-free and 5-year survival rates of patients with NQO1 overexpression were significantly lower than those of patients without NQO1 expression. Further analysis using a Cox proportional hazards regression model revealed that NQO1 expression emerged as a significant independent hazard factor for the 5-year survival rate of patients with HCC. Therefore, NQO1 plays an important role in the progression of HCC. NQO1 may potentially be used as an independent biomarker for prognostic evaluation of HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
高贵逍遥完成签到 ,获得积分10
刚刚
轮子发布了新的文献求助10
1秒前
构式pro完成签到,获得积分20
2秒前
3秒前
晚风完成签到 ,获得积分10
3秒前
3秒前
zhanyuji发布了新的文献求助10
5秒前
唐陌完成签到 ,获得积分10
6秒前
领导范儿应助Jodie采纳,获得10
7秒前
7秒前
7秒前
9秒前
10秒前
构式pro发布了新的文献求助10
10秒前
magernage完成签到,获得积分10
11秒前
11秒前
柳贯一应助ralph_liu采纳,获得20
12秒前
跳跃惜筠发布了新的文献求助30
12秒前
14秒前
萌萌小粥完成签到 ,获得积分10
17秒前
chenwenjun发布了新的文献求助10
17秒前
年轮完成签到 ,获得积分10
17秒前
可爱小熊猫完成签到,获得积分10
18秒前
20秒前
李健的小迷弟应助秋波采纳,获得30
22秒前
苹果完成签到 ,获得积分10
23秒前
26秒前
梦自然完成签到 ,获得积分10
29秒前
Jodie发布了新的文献求助10
30秒前
31秒前
Hello应助神内小大夫采纳,获得10
32秒前
chemstation完成签到 ,获得积分10
33秒前
能干砖头完成签到,获得积分20
35秒前
35秒前
搜集达人应助ZYN采纳,获得10
35秒前
小布丁发布了新的文献求助10
37秒前
40秒前
dongdoctor完成签到 ,获得积分10
40秒前
Liu完成签到,获得积分10
40秒前
跳跃惜筠发布了新的文献求助10
43秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6944437
求助须知:如何正确求助?哪些是违规求助? 8629885
关于积分的说明 18305557
捐赠科研通 6379654
什么是DOI,文献DOI怎么找? 3079291
关于科研通互助平台的介绍 2120203
邀请新用户注册赠送积分活动 2056180